Submitted by endpointsnews6292 in health
Pfizer’s Covid-19 antiviral did not improve symptoms in patients with long Covid compared to placebo — the latest disappointment for patients with the post-infection condition. Scientists at Stanford University found that patients receiving a 15-day course of…